skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Improved patient outcome with smoking cessation: when is it too late?

Review

(2599) Views  (880) Full article downloads

Authors: Wu J, Sin DD

Published Date May 2011 Volume 2011:6 Pages 259 - 267
DOI: http://dx.doi.org/10.2147/COPD.S10771

Jane Wu1, Don D Sin1,2
1Department of Medicine (Division of Respirology), The University of British Columbia, Vancouver, BC, Canada; 2UBC James Hogg Research Laboratory, Providence Heart and Lung Institute, St. Paul's Hospital, Vancouver, BC, Canada

Abstract: Smoking is the leading modifiable risk factor for chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD), and lung cancer. Smoking cessation is the only proven way of modifying the natural course of COPD. It is also the most effective way of reducing the risk for myocardial infarction and lung cancer. However, the full benefits of tobacco treatment may not be realized until many years of abstinence. All patients with COPD, regardless of severity, appear to benefit from tobacco treatment. Similarly, patients with recent CVD events also benefit from tobacco treatment. The risk of total mortality and rate of recurrence of lung cancer is substantially lower in smokers who manage to quit smoking following the diagnosis of early stage lung cancer or small cell lung cancer. Together, these data suggest that tobacco treatment is effective both as a primary and a secondary intervention in reducing total morbidity and mortality related to COPD, CVD, and lung cancer. In this paper, we summarize the evidence for tobacco treatment and the methods by which smoking cessation can be promoted in smokers with lung disease.

Keywords: COPD, lung cancer, tobacco treatment, smoking cessation






Readers of this article also read:

The pathophysiology of bronchiectasis
Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
Optimizing management of chronic obstructive pulmonary disease in the upcoming decade
Early detection of COPD in general practice
Lung injury after cigarette smoking is particle related
Hypoxemia in patients with COPD: cause, effects, and disease progression
Long-acting ß-adrenoceptor agonists in the management of COPD: focus on indacaterol
Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease
Outcome of pulmonary rehabilitation in COPD patients with severely impaired health status
Why are some evidence-based care recommendations in chronic obstructive pulmonary disease better implemented than others? Perspectives of medical practitioners
  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio